AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement
AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a…
Continue Reading-
-
Our client Northern Biologics Enters the Clinic with its lead immuno-oncology antibody, MSC-1
Northern Biologics Inc., a developer of first-in-class immuno-oncology products, today announced that its lead immuno-oncology…
Continue Reading -
Geoblink raises $6m and joins Metrix Partners’ client list
Location intelligence SaaS company, Geoblink, has today announced that it has secured a $6m…
Continue Reading -
What does it take to raise capital, in SaaS, in 2018?, by Christoph Janz
Note: this article was originally published in Medium by Christophe Janz, from Point Nine Capital What…
Continue Reading -
Our client ForceManager raises $12m in Series B Funding led by AXA Strategic Ventures
Post originally published in Nauta Capital’s blog on 06 Dec 2017 ForceManager raises $12m in…
Continue Reading -
Hire a CFO by Jeff Jordan, from Andreessen Horowitz
This post was originally pubished in A16Z’s blog here. Many CEOs think the chief financial officer…
Continue Reading -
Our client Aelix commences enrolment in Phase I trial for HIV vaccine
Spanish biotechnology firm Aelix Therapeutics has commenced patient enrolment in a Phase I clinical trial…
Continue Reading -
-
-
